ATE238287T1 - 6-azauracilderivate als il-5 inhibitoren - Google Patents
6-azauracilderivate als il-5 inhibitorenInfo
- Publication number
- ATE238287T1 ATE238287T1 AT99963332T AT99963332T ATE238287T1 AT E238287 T1 ATE238287 T1 AT E238287T1 AT 99963332 T AT99963332 T AT 99963332T AT 99963332 T AT99963332 T AT 99963332T AT E238287 T1 ATE238287 T1 AT E238287T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- azauracil derivatives
- azauracil
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98203929 | 1998-11-23 | ||
PCT/EP1999/009154 WO2000031053A1 (en) | 1998-11-23 | 1999-11-22 | Il-5 inhibiting 6-azauracil derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE238287T1 true ATE238287T1 (de) | 2003-05-15 |
Family
ID=8234365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99963332T ATE238287T1 (de) | 1998-11-23 | 1999-11-22 | 6-azauracilderivate als il-5 inhibitoren |
Country Status (11)
Country | Link |
---|---|
US (1) | US6498158B1 (de) |
EP (1) | EP1133483B1 (de) |
JP (1) | JP2002530390A (de) |
AR (1) | AR021362A1 (de) |
AT (1) | ATE238287T1 (de) |
AU (1) | AU759405B2 (de) |
CA (1) | CA2352503C (de) |
DE (1) | DE69907254T2 (de) |
ES (1) | ES2198980T3 (de) |
TR (1) | TR200101425T2 (de) |
WO (1) | WO2000031053A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1275596C (zh) | 1997-05-14 | 2006-09-20 | 阿特罗吉尼克斯公司 | 普罗布考单酯在制备用于治疗心血管疾病和炎性疾病的药物中的应用 |
US6670398B2 (en) | 1997-05-14 | 2003-12-30 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
JP2010522762A (ja) | 2007-03-26 | 2010-07-08 | サルトリア・フアーマシユーテイカルズ・エル・エル・シー | 糖尿病の治療のための方法及びプロブコール誘導体の組成物 |
JP2011507909A (ja) | 2007-12-20 | 2011-03-10 | エンビボ ファーマシューティカルズ インコーポレイテッド | 四置換ベンゼン |
CN112441941B (zh) * | 2020-12-03 | 2022-08-02 | 浙江荣耀生物科技股份有限公司 | 一种1-(4-氨基苯基)环戊基甲腈的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW332201B (en) | 1995-04-06 | 1998-05-21 | Janssen Pharmaceutica Nv | 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives |
-
1999
- 1999-11-22 TR TR2001/01425T patent/TR200101425T2/xx unknown
- 1999-11-22 AR ARP990105941A patent/AR021362A1/es unknown
- 1999-11-22 EP EP99963332A patent/EP1133483B1/de not_active Expired - Lifetime
- 1999-11-22 AT AT99963332T patent/ATE238287T1/de not_active IP Right Cessation
- 1999-11-22 JP JP2000583881A patent/JP2002530390A/ja not_active Withdrawn
- 1999-11-22 AU AU19677/00A patent/AU759405B2/en not_active Ceased
- 1999-11-22 CA CA002352503A patent/CA2352503C/en not_active Expired - Fee Related
- 1999-11-22 ES ES99963332T patent/ES2198980T3/es not_active Expired - Lifetime
- 1999-11-22 US US09/856,626 patent/US6498158B1/en not_active Expired - Fee Related
- 1999-11-22 DE DE69907254T patent/DE69907254T2/de not_active Expired - Fee Related
- 1999-11-22 WO PCT/EP1999/009154 patent/WO2000031053A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
AU759405B2 (en) | 2003-04-17 |
AU1967700A (en) | 2000-06-13 |
WO2000031053A1 (en) | 2000-06-02 |
TR200101425T2 (tr) | 2002-02-21 |
CA2352503C (en) | 2009-04-07 |
ES2198980T3 (es) | 2004-02-01 |
EP1133483A1 (de) | 2001-09-19 |
DE69907254T2 (de) | 2004-04-01 |
EP1133483B1 (de) | 2003-04-23 |
DE69907254D1 (de) | 2003-05-28 |
AR021362A1 (es) | 2002-07-17 |
CA2352503A1 (en) | 2000-06-02 |
US6498158B1 (en) | 2002-12-24 |
JP2002530390A (ja) | 2002-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69930518D1 (de) | Als antikrebsmittel verwendbare alkinyl-substituierte chinolin-2-on-derivate | |
ATE437862T1 (de) | Pyrimidin-5-onderivate als ldl-pla2 inhibitoren | |
NO20010193L (no) | Tiobenzimidazol-derivater | |
DE69725465D1 (de) | 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren | |
ATE236136T1 (de) | Benzosulfonderivate | |
DE69934788D1 (de) | Biozide benzylbiphenylderivative | |
DE69906311D1 (de) | Diarylbenzopyranderivate als cyclooxygenase-2-inhibitoren | |
NO20010514D0 (no) | Aminometylkarboksylsyre-derivater | |
ATE259810T1 (de) | Phenyl-xanthinderivate | |
ATE338021T1 (de) | Substituierte 2-dialkylaminoalkylbiphenyl- derivate | |
NO20020565L (no) | Interleukin-5-hemmende 6-azauracilderivater | |
DE69837922D1 (de) | Il-5 hemmende 6-azauracilderivate | |
ATE240317T1 (de) | Indolderivate als pkc-inhibitoren | |
DE60003072D1 (de) | Thiazolidindion-derivate als antidiabetika | |
DK1115716T3 (da) | 2-phenylpyran-4-on-derivater | |
DK1134219T3 (da) | Cucloalkylsubstituerede aminomethylpyrrolidinderivater | |
ATE233253T1 (de) | Chromanderivate | |
TR200002831A3 (tr) | Kinolin-4-Il türevleri I | |
DE69907254D1 (de) | 6-azauracilderivate als il-5 inhibitoren | |
EE9900585A (et) | 6-asauratsiili derivaadid IL-5 inhibiitoritena | |
DK1140873T3 (da) | IL-5-inhiberende 6-azauracilderivater | |
DE59907635D1 (de) | Pyrazolyldioxothiochromanoyl-derivate | |
DE69923861D1 (de) | Il-5 hemmende 6-azauracilderivate | |
ATE264308T1 (de) | Aminoalkyl-3,4-dihydrochinolin-derivate als no synthase inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |